On August 23, 2022, Biotia, Inc. closed the transaction. The round of funding led by a new investor OCA Ventures IV, L.P., a fund managed by OCA Venture Partners, LLC. The transaction also included participation from other new investors Phoenix Venture Partners LLC, SK Square Co., Ltd., Continuum Health Ventures, DigitalDx Ventures, and SeedToB Capital.